Dr Stephanie Kuku
Chief Knowledge and Operating Officer
Conceivable Life Sciences
London, United Kingdom
My organisation
About me
Stephanie is Chief Knowledge and Operating Officer for Conceivable Life Sciences, a New-York based biotech company. She serves as a Board trustee and on the Investment Committee of the King's Fund, the UK’s foremost healthcare thinktank and the Digital Health Innovation and AI expert on the UK Prix Galien Judging Committee.
Stephanie serves as Senior Advisor on Clinical AI Implementation at WHO’s Department of Digital Health & Innovation. She was previously a Senior Consultant at Hardian Health, a leading consultancy in health technology and AI. With a background as a Clinician-Scientist, she spent over 15 as a clinician-scientist at Britain’s National Health Service and HCA Healthcare. During her clinical career Stephanie sat on the council of the British Gynaecological Cancer Society and was awarded numerous international travelling fellowships including to Memorial Sloane Kettering Cancer Centre in New York, Cancer Hospital Pernambuco in Brazil, and Centre du Cancer Oscar Lambret in France.
She was awarded a Doctorate in Clinical Research at UCL where she remains an Honorary Senior Research Fellow with recent publications focused on Health AI and Data.
Stephanie serves on the Advisory Board of numerous organizations and Venture Funds, with a focus on Technology and Innovation implementation in Healthcare.
Stephanie is a regular speaker on AI and Future of Health and has previously co-hosted a podcast series for HLTH health summit in the US.
STARTUP
State your investment phases
Name a few of your investments:
tbc
What is your ticket size (SEK / Euro)?
tbc
Speaker sessions (1)
Wednesday, 28 January 2026
10:01 - 10:21
Code Meets Care: Where Healthcare Meets AI, Data and Next-Gen Compute
- Life Science
- Trends
- Tech
- AI
Join a panel where we unpack what the future of healthcare looks like when code meets care — and how Europe can lead in building safe, scalable, and truly impactful health technologies.